Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-Fos immunoreactivity

Biological Psychiatry

Volumn 50, Issue 7, 2001, Pages 510-520

  Dawe, Gavin S ^a   Huff, Keith D ^a   Vandergriff, Jim L ^a   Sharp, Trevor ^b   O'Neill, Michael J ^a   Rasmussen, Kurt ^a  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atypical antipsychotics; Burst firing; c Fos; Clozapine; Locus coeruleus; Olanzapine

Indexed keywords

CLOZAPINE; OLANZAPINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ELECTROPHYSIOLOGY; GENE EXPRESSION; IMMUNOREACTIVITY; IN VIVO STUDY; LOCUS CERULEUS; MALE; NERVE CONDUCTION; NONHUMAN; NORADRENERGIC SYSTEM; ONCOGENE C FOS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SYMPTOM; TISSUE DISTRIBUTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; LOCUS COERULEUS; MALE; NEURONS; NOREPINEPHRINE; PIRENZEPINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035477920     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01171-4     Document Type: Article

References (55)

1. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: An in vivo microdialysis study
2. Afferent regulation of locus coeruleus neurons: Anatomy, physiology and pharmacology
3. Immunohistochemical studies of noradrenergic-induced expression of c-fos in the rat CNS
4. Radioreceptor binding profile of the atypical antipsychotic olanzapine
5. Olanzapine: A basic science update
6. Activation of locus coeruleus neurons by peripheral stimuli: Modulation by a collateral inhibitory mechanism
7. Spatially and temporally differentiated patterns of c-fos expression in brainstem catecholaminergic cell groups induced by cardiovascular challenges in the rat
8. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: Cellular localization and pharmacological characterization
9. Acute haloperidol increases impulse activity of brain noradrenergic neurons
10. Hemodynamic stress activates locus coeruleus neurons of unanesthetized rats
11. C-fos expression as a marker of central cardiovascular neurons
12. Activation of locus coeruleus neurons by nucleus paragigantocellularis or noxious sensory stimulation is mediated by intracoerulear excitatory amino acid neurotransmission
13. Enhanced norepinephrine release in prefrontal cortex with burst stimulation of the locus coeruleus
14. Neurochemical and electrophysiological studies on the functional significance of burst firing in serotonergic neurons
15. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex
16. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons-1. Identification and characterization
17. The control of firing pattern in nigral dopamine neurons: Burst firing
18. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: An in vivo electrophysiological study in the rat
19. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain
20. Central noradrenergic neurons: The autonomic connection
21. Comparative effects of sciatic nerve stimulation, blood pressure, and morphine on the activity of A5 and A6 pontine noradrenergic neurons
22. A study of the effect of atypical antipsychotic drugs on noradrenergic transmission using Fos immunocytochemistry
23. Distribution of dopamine-immunoreactive fibers in the rat brainstem
24. Exploratory pilot study with olanzapine in generalized anxiety disorder (GAD) showed anxiolytic treatment with low-dosages of the atypical antipsychotic
25. Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons
26. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum
27. Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy
28. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
29. Quantitative image analysis for immunocytochemistry and in situ hybridization
30. Directionally specific changes in arterial pressure induce differential patterns of fos expression in discrete areas of the rat brainstem: A double-labeling study for Fos and catecholamines
31. Clozapine- and olanzapine-induced Fos expression in the rat medial prefrontal cortex is mediated by beta-adrenoceptors
32. The locus coeruleus: Actions of psychoactive drugs
33. Effects of 5-hydroxytryptamine 2 receptor antagonism on the behavioral activation and immediate early gene expression induced by dizocilpine
34. Locus coeruleus activation by physiological challenges
35. Olanzapine therapy for posttraumatic stress disorder
36. Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol
37. Locus coeruleus norepinephrine-containing neurons: Effects produced by acute and subchronic treatment with antipsychotic drugs and amphetamine
38. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: Reversal by selective 5-HT2 antagonists
39. A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
40. Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine
41. Effects of olanzapine on regional c-Fos expression in rat forebrain
42. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity
43. Olanzapine safety and efficacy in patients with borderline personality disorder and comorbid dysthymia
44. Olanzapine-induced fos expression in the rat forebrain: Cross-tolerance with haloperidol and clozapine
45. Effects of clozapine on the activity of central dopaminergic and noradrenergic neurons
46. Adrenoceptor antagonists block c-fos response to stress in the mouse brain
47. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area
48. Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The olanzapine HGGW Study Group
49. A double-blind controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia
50. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal
51. Schizophrenia and the frontal lobe
52. Prefrontal function in schizophrenia: Confounds and controversies
53. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain
54. Negative symptoms and hypofrontality in chronic schizophrenia